Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 30;11(10):366.
doi: 10.21037/atm-23-1051. Epub 2023 Apr 11.

De-escalating postoperative radiation therapy after primary systemic therapy in cT1-2N1 breast cancer: lesson from the RAPCHEM/BOOG 2010-03 trial

Marco Banini  1   2 , Luca Visani  1   2 , Lorenzo Livi  1   2 , Icro Meattini  1   2
Affiliations
Editorial

De-escalating postoperative radiation therapy after primary systemic therapy in cT1-2N1 breast cancer: lesson from the RAPCHEM/BOOG 2010-03 trial

Marco Banini et al. Ann Transl Med. .
No abstract available

Keywords: Breast cancer; chemotherapy; de-escalation; primary systemic therapy (PST); radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-23-1051/coif). IM disclosed occasional fees for advisory board supported by Novartis, Eli Lilly, Pfizer, Seagen, Gilead, and Accuray. The other authors have no conflicts of interests to disclose.

Comment on

References

    1. Lurie RH, Aft R, Balassanian R, et al. NCCN guidelines version 4. 2022 breast cancer. Available online: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
    1. Murchison S, Truong P. Locoregional therapy in breast cancer patients treated with neoadjuvant chemotherapy. Expert Rev Anticancer Ther 2021;21:865-75. 10.1080/14737140.2021.1903876 - DOI - PubMed
    1. Reinert T, de Souza ABA, Sartori GP, et al. Highlights of the 17th St Gallen International Breast Cancer Conference 2021: customising local and systemic therapies. Ecancermedicalscience 2021;15:1236. 10.3332/ecancer.2021.1236 - DOI - PMC - PubMed
    1. Wang X, Xu L, Yin Z, et al. Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy. Cancer Manag Res 2018;10:4105-12. 10.2147/CMAR.S173628 - DOI - PMC - PubMed
    1. Mamounas EP, Anderson SJ, Dignam JJ, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 2012;30:3960-6. 10.1200/JCO.2011.40.8369 - DOI - PMC - PubMed